Reaction
Positron Emission Tomogram Abnormal reporting signals
As of the last recalculation, Positron Emission Tomogram Abnormal appears in 682 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is NIRAPARIB (PRR 133.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Niraparib | 85 | 133.4 | 133.9 |
| Ribociclib | 56 | 58.9 | 59.0 |
| Rucaparib | 12 | 42.2 | 42.3 |
| Fulvestrant | 36 | 35.1 | 35.1 |
| Polatuzumab Vedotin | 8 | 25.3 | 25.3 |
| Relugolix | 10 | 13.1 | 13.1 |
| Ifosfamide | 9 | 12.9 | 12.9 |
| Palbociclib | 27 | 9.0 | 9.0 |
| Durvalumab | 5 | 7.5 | 7.6 |